Source:http://linkedlifedata.com/resource/pubmed/id/14767809
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-2-9
|
pubmed:abstractText |
Nonphysiological overexpression of the ABC transporter P-glycoprotein (P-gp), which is encoded by MDR1, has been associated with reduced susceptibility to human immunodeficiency virus (HIV) type 1 infection in vitro. We analyzed (1) the expression and genotype of MDR1 and their relationship to HIV-1 permissiveness of CD4+ T cells from 128 healthy blood donors and (2) the role that alleles of MDR1 exons 21 and 26 play in modifying disease progression in 411 HIV-1-infected individuals. Differences in physiological levels of MDR1 expression did not modify HIV-1 infection in vitro, nor did MDR1 alleles and haplotypes significantly influence either permissiveness to infection in vitro or disease progression in vivo before the initiation of treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
189
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
583-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:14767809-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:14767809-Base Sequence,
pubmed-meshheading:14767809-CD4-Positive T-Lymphocytes,
pubmed-meshheading:14767809-Cohort Studies,
pubmed-meshheading:14767809-DNA Primers,
pubmed-meshheading:14767809-Disease Progression,
pubmed-meshheading:14767809-Genes, MDR,
pubmed-meshheading:14767809-Genetic Variation,
pubmed-meshheading:14767809-Genotype,
pubmed-meshheading:14767809-HIV Infections,
pubmed-meshheading:14767809-HIV-1,
pubmed-meshheading:14767809-Humans,
pubmed-meshheading:14767809-Polymorphism, Genetic
|
pubmed:year |
2004
|
pubmed:articleTitle |
MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.
|
pubmed:affiliation |
Institute of Microbiology and Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|